(RBC) RBC Bearings - Overview
Stock: Bearings, Gears, Hydraulics, Fasteners, Valves
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 24.6% |
| Relative Tail Risk | -12.5% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.49 |
| Alpha | 32.67 |
| Character TTM | |
|---|---|
| Beta | 0.906 |
| Beta Downside | 0.751 |
| Drawdowns 3y | |
|---|---|
| Max DD | 19.71% |
| CAGR/Max DD | 1.64 |
Description: RBC RBC Bearings January 03, 2026
RBC Bearings Incorporated (NYSE:RBC) designs, manufactures, and markets precision bearings, components, and power-transmission systems for both aerospace/defense and industrial customers. Its product portfolio spans self-lubricating plain bearings, tapered and needle roller bearings, high-precision ball bearings, mounted bearing assemblies, enclosed gearmotors, couplings, hydraulic valves, fasteners, and machine-tool collets, serving a broad end-use base that includes commercial and military aircraft, construction, mining, energy, semiconductor equipment, and rail transportation.
In its most recent fiscal year (2023), RBC reported roughly $1.2 billion in revenue with an operating margin near 9 % and generated about $120 million of free cash flow, supporting a backlog of roughly $600 million that is weighted toward aerospace and defense contracts. The company’s performance is closely tied to two macro-drivers: (1) sustained defense spending growth, which underpins demand for high-reliability bearings in military aircraft and submarines; and (2) the post-pandemic rebound in commercial aviation and industrial automation, which fuels higher utilization of its low-friction, high-speed bearing solutions. A key risk is the cyclicality of the industrial segment, which can be amplified by commodity price swings and supply-chain bottlenecks in raw-material inputs such as specialty steels.
If you want a data-rich, quantitative view of RBC’s valuation dynamics, a quick look at the ValueRay platform can help surface the most relevant metrics and scenario analyses.
Piotroski VR‑10 (Strict, 0-10) 7.5
| Net Income: 268.6m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA 0.87 > 1.0 |
| NWC/Revenue: 31.52% < 20% (prev 44.07%; Δ -12.55% < -1%) |
| CFO/TA 0.08 > 3% & CFO 399.7m > Net Income 268.6m |
| Net Debt (240.7m) to EBITDA (521.9m): 0.46 < 3 |
| Current Ratio: 1.86 > 1.5 & < 3 |
| Outstanding Shares: last quarter (31.6m) vs 12m ago 1.35% < -2% |
| Gross Margin: 44.32% > 18% (prev 0.44%; Δ 4388 % > 0.5%) |
| Asset Turnover: 36.52% > 50% (prev 34.56%; Δ 1.96% > 0%) |
| Interest Coverage Ratio: 7.78 > 6 (EBITDA TTM 521.9m / Interest Expense TTM 51.4m) |
Altman Z'' 3.24
| A: 0.11 (Total Current Assets 1.22b - Total Current Liabilities 656.4m) / Total Assets 5.14b |
| B: 0.32 (Retained Earnings 1.65b / Total Assets 5.14b) |
| C: 0.08 (EBIT TTM 399.7m / Avg Total Assets 4.90b) |
| D: 0.88 (Book Value of Equity 1.65b / Total Liabilities 1.88b) |
| Altman-Z'' Score: 3.24 = A |
Beneish M -3.00
| DSRI: 1.00 (Receivables 285.8m/256.1m, Revenue 1.79b/1.61b) |
| GMI: 0.99 (GM 44.32% / 44.10%) |
| AQI: 0.96 (AQ_t 0.67 / AQ_t-1 0.70) |
| SGI: 1.11 (Revenue 1.79b / 1.61b) |
| TATA: -0.03 (NI 268.6m - CFO 399.7m) / TA 5.14b) |
| Beneish M-Score: -3.00 (Cap -4..+1) = A |
What is the price of RBC shares?
Over the past week, the price has changed by +8.88%, over one month by +14.36%, over three months by +25.95% and over the past year by +48.91%.
Is RBC a buy, sell or hold?
- StrongBuy: 3
- Buy: 1
- Hold: 3
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the RBC price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 528.2 | -2.9% |
| Analysts Target Price | 528.2 | -2.9% |
| ValueRay Target Price | 722.2 | 32.8% |
RBC Fundamental Data Overview February 07, 2026
P/E Forward = 14.5349
P/S = 9.541
P/B = 5.1256
P/EG = 1.4525
Revenue TTM = 1.79b USD
EBIT TTM = 399.7m USD
EBITDA TTM = 521.9m USD
Long Term Debt = 918.4m USD (from longTermDebt, last fiscal year)
Short Term Debt = 298.4m USD (from shortTermDebt, last quarter)
Debt = 348.3m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 240.7m USD (from netDebt column, last quarter)
Enterprise Value = 16.68b USD (16.44b + Debt 348.3m - CCE 107.6m)
Interest Coverage Ratio = 7.78 (Ebit TTM 399.7m / Interest Expense TTM 51.4m)
EV/FCF = 50.54x (Enterprise Value 16.68b / FCF TTM 330.1m)
FCF Yield = 1.98% (FCF TTM 330.1m / Enterprise Value 16.68b)
FCF Margin = 18.44% (FCF TTM 330.1m / Revenue TTM 1.79b)
Net Margin = 15.00% (Net Income TTM 268.6m / Revenue TTM 1.79b)
Gross Margin = 44.32% ((Revenue TTM 1.79b - Cost of Revenue TTM 997.0m) / Revenue TTM)
Gross Margin QoQ = 44.28% (prev 44.06%)
Tobins Q-Ratio = 3.24 (Enterprise Value 16.68b / Total Assets 5.14b)
Interest Expense / Debt = 3.73% (Interest Expense 13.0m / Debt 348.3m)
Taxrate = 24.52% (21.9m / 89.3m)
NOPAT = 301.7m (EBIT 399.7m * (1 - 24.52%))
Current Ratio = 1.86 (Total Current Assets 1.22b / Total Current Liabilities 656.4m)
Debt / Equity = 0.11 (Debt 348.3m / totalStockholderEquity, last quarter 3.26b)
Debt / EBITDA = 0.46 (Net Debt 240.7m / EBITDA 521.9m)
Debt / FCF = 0.73 (Net Debt 240.7m / FCF TTM 330.1m)
Total Stockholder Equity = 3.15b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.48% (Net Income 268.6m / Total Assets 5.14b)
RoE = 8.53% (Net Income TTM 268.6m / Total Stockholder Equity 3.15b)
RoCE = 9.83% (EBIT 399.7m / Capital Employed (Equity 3.15b + L.T.Debt 918.4m))
RoIC = 7.39% (NOPAT 301.7m / Invested Capital 4.08b)
WACC = 9.13% (E(16.44b)/V(16.79b) * Re(9.26%) + D(348.3m)/V(16.79b) * Rd(3.73%) * (1-Tc(0.25)))
Discount Rate = 9.26% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 4.09%
[DCF Debug] Terminal Value 77.09% ; FCFF base≈301.6m ; Y1≈358.2m ; Y5≈558.9m
Fair Price DCF = 237.3 (EV 7.74b - Net Debt 240.7m = Equity 7.50b / Shares 31.6m; r=9.13% [WACC]; 5y FCF grow 20.01% → 2.90% )
EPS Correlation: 74.78 | EPS CAGR: 26.47% | SUE: 4.0 | # QB: 5
Revenue Correlation: 91.71 | Revenue CAGR: 6.94% | SUE: 0.24 | # QB: 0
EPS next Quarter (2026-06-30): EPS=3.34 | Chg30d=+0.050 | Revisions Net=+2 | Analysts=3
EPS next Year (2027-03-31): EPS=13.55 | Chg30d=+0.099 | Revisions Net=+3 | Growth EPS=+12.6% | Growth Revenue=+11.2%